• Product name

  • Description

    Goat polyclonal to CYLD
  • Host species

  • Tested applications

    Suitable for: ELISA, WBmore details
  • Species reactivity

    Reacts with: Mouse, Rat
    Predicted to work with: Horse, Cow, Dog, Human, Chimpanzee, Orangutan
  • Immunogen

    Synthetic peptide:


    , corresponding to internal sequence amino acids 361-375 of Mouse CYLD

  • Positive control

    • Brain lysate.



Our Abpromise guarantee covers the use of ab60266 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notes
    Peptide ELISA: antibody detection limit dilution 1/32000.
    WB: Use at a concentration of 0.5 - 1.5 µg/ml. Detects a band of approximately 120 kDa (predicted molecular weight: 107 kDa).

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Function

      Protease that specifically cleaves 'Lys-63'-linked polyubiquitin chains. Has endodeubiquitinase activity. Plays an important role in the regulation of pathways leading to NF-kappa-B activation. Contributes to the regulation of cell survival, proliferation and differentiation via its effects on NF-kappa-B activation. Negative regulator of Wnt signaling. Inhibits HDAC6 and thereby promotes acetylation of alpha-tubulin and stabilization of microtubules. Plays a role in the regulation of microtubule dynamics, and thereby contributes to the regulation of cell proliferation, cell polarization, cell migration, and angiogenesis. Required for normal cell cycle progress and normal cytokinesis. Inhibits nuclear translocation of NF-kappa-B. Plays a role in the regulation of inflammation and the innate immune response, via its effects on NF-kappa-B activation. Dispensable for the maturation of intrathymic natural killer cells, but required for the continued survival of immature natural killer cells. Negatively regulates TNFRSF11A signaling and osteoclastogenesis.
    • Tissue specificity

      Detected in fetal brain, testis, and skeletal muscle, and at a lower level in adult brain, leukocytes, liver, heart, kidney, spleen, ovary and lung. Isoform 2 is found in all tissues except kidney.
    • Involvement in disease

      Defects in CYLD are the cause of familial cylindromatosis (FCYL) [MIM:132700]; also known as Ancell-Spiegler cylindromas or turban tumor syndrome or dermal eccrine cylindromatosis. CYLD is an autosomal dominant and highly tumor type-specific disorder. The tumors (known as cylindromas because of their characteristic microscopic architecture) are believed to arise from or recapitulate the appearance of the eccrine or apocrine cells of the skin that secrete sweat and scent respectively. Cylindromas arise predominantly in hairy parts of the body with approximately 90% on the head and neck. The development of a confluent mass which may ulcerate or become infected has led to the designation 'turban tumor syndrome'. The skin tumors show differentiation in the direction of hair structures, hence the synonym trichoepithelioma.
      Defects in CYLD are the cause of multiple familial trichoepithelioma type 1 (MFT1) [MIM:601606]; also known as epithelioma adenoides cysticum of Brooke (EAC) or hereditary multiple benign cystic epithelioma or Brooke-Fordyce trichoepitheliomas. MFT1 is an autosomal dominant dermatosis characterized by the presence of many skin tumors predominantly on the face. Since histologic examination shows dermal aggregates of basaloid cells with connection to or differentiation toward hair follicles, this disorder has been thought to represent a benign hamartoma of the pilosebaceous apparatus. Trichoepitheliomas can degenerate into basal cell carcinoma.
      Defects in CYLD are the cause of Brooke-Spiegler syndrome (BRSS) [MIM:605041]. BRSS is an autosomal dominant disorder characterized by the appearance of multiple skin appendage tumors such as cylindroma, trichoepithelioma, and spiradenoma. These tumors are typically located in the head and neck region, appear in early adulthood, and gradually increase in size and number throughout life.
    • Sequence similarities

      Belongs to the peptidase C67 family.
      Contains 3 CAP-Gly domains.
    • Post-translational

      Phosphorylated on several serine residues by IKKA and/or IKKB in response to immune stimuli. Phosphorylation requires IKBKG. Phosphorylation abolishes TRAF2 deubiquitination, interferes with the activation of Jun kinases, and strongly reduces CD40-dependent gene activation by NF-kappa-B.
    • Cellular localization

      Cytoplasm. Cytoplasm > perinuclear region. Cytoplasm > cytoskeleton. Cell membrane. Detected at the microtubule cytoskeleton during interphase. Detected at the midbody during telophase.
    • Information by UniProt
    • Database links

    • Alternative names

      • BRSS antibody
      • CDMT antibody
      • Cyld antibody
      • CYLD gene antibody
      • CYLD_HUMAN antibody
      • CYLD1 antibody
      • CYLDI antibody
      • cylindromatosis (turban tumor syndrome) antibody
      • cylindromatosis 1 antibody
      • Deubiquitinating enzyme CYLD antibody
      • EAC antibody
      • HSPC057 antibody
      • KIAA0849 antibody
      • MFT antibody
      • MFT1 antibody
      • Probable ubiquitin carboxyl terminal hydrolase CYLD antibody
      • SBS antibody
      • TEM antibody
      • turban tumor syndrome antibody
      • Ubiquitin carboxyl-terminal hydrolase CYLD antibody
      • ubiquitin specific peptidase like 2 antibody
      • ubiquitin thioesterase CYLD antibody
      • Ubiquitin thiolesterase CYLD antibody
      • Ubiquitin-specific processing protease CYLD antibody
      • Ubiquitin-specific-processing protease CYLD antibody
      • USPL2 antibody
      see all


    • ab60266 antibody (0.5µg/ml) staining of CYLD in Rat Brain lysate (35µg protein in RIPA buffer)
      Predicted band size: 107 kDa
      Observed band size: 120 kDa
      why is the actual band size different from the predicted?

      Primary incubation was 1 hour. Detected by chemiluminescence.


    ab60266 has not yet been referenced specifically in any publications.

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab60266.
    Please use the links above to contact us or submit feedback about this product.

    For licensing inquiries, please contact partnerships@abcam.com

    Sign up